1
|
López R, Pérez-Araos R, Baus F, Moscoso C, Salazar Á, Graf J, Montes JM, Samtani S. Outcomes of Sepsis and Septic Shock in Cancer Patients: Focus on Lactate. Front Med (Lausanne) 2021; 8:603275. [PMID: 33981712 PMCID: PMC8107210 DOI: 10.3389/fmed.2021.603275] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2020] [Accepted: 03/05/2021] [Indexed: 12/29/2022] Open
Abstract
The number of oncological patients (OP) admitted to intensive care units (ICU) for sepsis/septic shock has dramatically increased in recent years. The definition of septic shock has been modified, adding hyperlactatemia as a severity biomarker for mortality. However, it remains poorly reported in septic OP. We performed a retrospective analysis from a prospective database of sepsis/septic shock patients admitted to our ICU between September 2017 and September 2019 and followed until day 90. We identified 251 patients and 31.9% had active oncological comorbidity, mainly solid tumor (81.3%). Septic shock criteria were met for 112 (44.6%). Hyperlactatemia was observed in 136 (54.2%) patients and this was associated with a lower survival rate. Overall 90-day mortality was 15.1%. In OP vs. non-OP, hyperlactatemia was more frequent (65% vs. 49.1%, p = 0.013) and associated with lower survival (65.4% vs. 85.7%, p = 0.046). In OP, poor performance status was also associated with lower survival (HR 7.029 [1.998-24.731], p = 0.002) In an adjusted analysis, cancer was associated with lower 90-day survival (HR 2.690 [1.402-5.160], p = 0.003). In conclusion, septic OP remains a high mortality risk group in whom lactate levels and performance status could help with better risk stratification.
Collapse
Affiliation(s)
- René López
- Departamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago, Chile.,Escuela de Medicina, Facultad de Medicina Clínica Alemana - Universidad del Desarrollo, Santiago, Chile
| | - Rodrigo Pérez-Araos
- Departamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago, Chile.,Escuela de Kinesiología, Facultad de Medicina Clínica Alemana - Universidad del Desarrollo, Santiago, Chile
| | - Fernanda Baus
- Escuela de Kinesiología, Facultad de Medicina Clínica Alemana - Universidad del Desarrollo, Santiago, Chile
| | - Camila Moscoso
- Departamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago, Chile
| | - Álvaro Salazar
- Departamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago, Chile
| | - Jerónimo Graf
- Departamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago, Chile.,Escuela de Medicina, Facultad de Medicina Clínica Alemana - Universidad del Desarrollo, Santiago, Chile
| | - José Miguel Montes
- Departamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago, Chile.,Escuela de Medicina, Facultad de Medicina Clínica Alemana - Universidad del Desarrollo, Santiago, Chile
| | - Suraj Samtani
- Departamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago, Chile.,Escuela de Medicina, Facultad de Medicina Clínica Alemana - Universidad del Desarrollo, Santiago, Chile.,Medical Oncology, Fundación Chilena de Inmuno Oncologia, Santiago, Chile.,Medical Oncology Service, Clinica Bradford Hill, Santiago, Chile
| |
Collapse
|
2
|
Oliynyk OV, Rorat M, Barg W. Oxygen metabolism markers as predictors of mortality in severe COVID-19. Int J Infect Dis 2020; 103:452-456. [PMID: 33310024 PMCID: PMC7833681 DOI: 10.1016/j.ijid.2020.12.012] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2020] [Revised: 12/01/2020] [Accepted: 12/06/2020] [Indexed: 12/20/2022] Open
Abstract
Objective To investigate the use of oxygen metabolism markers as predictors of mortality in patients with severe coronavirus disease 2019 (COVID-19). Methods A retrospective analysis was undertaken to compare the medical records of patients with severe COVID-19 (53 deceased patients and 50 survivors). The survivors were selected from 222 records using a random number generator. In addition, 28 individuals who considered themselves to be healthy and who had no history of serious illness were included in the study for comparison. Oxygen saturation in arterial blood, oxygen saturation in central venous blood (ScvO2), arterial partial pressure of oxygen (PaO2), respiratory index (PaO2/fraction of inspired oxygen), oxygen delivery, oxygen consumption (VO2) and oxygen extraction (O2ER) were compared in all participants. The optimal cut-off point for each oxygen metabolism marker in the prediction of mortality was determined based on the maximum value of the Youden Index in receiver operating characteristic curve analysis. Results Significant differences in all studied oxygen metabolism markers were found between survivors compared with deceased patients (p < 0.001). ScvO2, VO2 and O2ER [area under curve (AUC) 1.0] were the strongest predictors of mortality, and PaO2 was the weakest predictor of mortality (AUC 0.81). ScvO2 <29%, VO2 >124.6 ml/min and O2ER >30.2% were identified as predictors of mortality in patients with COVID-19. Conclusion ScvO2, VO2 and O2ER are good predictors of mortality in critically ill patients with COVID-19.
Collapse
Affiliation(s)
- Oleksandr V Oliynyk
- Department of Anaesthesiology and Intensive Care, Bogomolets National Medical University, Kiev, Ukraine; Department of Emergency Medicine, High Education State School named by Pope John Paul II, Biala Podlaska, Poland
| | - Marta Rorat
- I Infectious Diseases Ward, J. Gromkowski Regional Specialist Hospital, Wroclaw, Poland; Department of Forensic Medicine, Wroclaw Medical University, Wroclaw, Poland.
| | - Wojciech Barg
- Department of Internal Medicine, Pneumonology and Allergology, Wroclaw Medical University, Wroclaw, Poland
| |
Collapse
|
3
|
Peyrony O, Fontaine JP, Beaune S, Khoury A, Truchot J, Balen F, Vally R, Schmitt J, Ben Hammouda K, Roussel M, Borzymowski C, Vallot C, Sanh V, Azoulay E, Chevret S. EPICANCER-Cancer Patients Presenting to the Emergency Departments in France: A Prospective Nationwide Study. J Clin Med 2020; 9:jcm9051505. [PMID: 32429507 PMCID: PMC7291158 DOI: 10.3390/jcm9051505] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2020] [Revised: 05/12/2020] [Accepted: 05/14/2020] [Indexed: 01/20/2023] Open
Abstract
Background: We aimed to estimate the prevalence of cancer patients who presented to Emergency Departments (EDs), report their chief complaint and identify the predictors of 30-day all-cause mortality. Patients and methods: we undertook a prospective, cross-sectional study during three consecutive days in 138 EDs and performed a logistic regression to identify the predictors of 30-day mortality in hospitalized patients. Results: A total of 1380 cancer patients were included. The prevalence of cancer patients among ED patients was 2.8%. The most frequent reasons patients sought ED care were fatigue (16.6%), dyspnea (16.3%), gastro-intestinal disorders (15.1%), trauma (13.0%), fever (12.5%) and neurological disorders (12.5%). Patients were admitted to the hospital in 64.9% of cases, of which 13.4% died at day 30. Variables independently associated with a higher mortality at day 30 were male gender (Odds Ratio (OR), 1.63; 95% CI, 1.04–2.56), fatigue (OR, 1.65; 95% CI, 1.01–2.67), poor performance status (OR, 3.00; 95% CI, 1.87–4.80), solid malignancy (OR, 3.05; 95% CI, 1.26–7.40), uncontrolled malignancy (OR, 2.27; 95% CI, 1.36–3.80), ED attendance for a neurological disorder (OR, 2.38; 95% CI, 1.36–4.19), high shock-index (OR, 1.80; 95% CI, 1.03–3.13) and oxygen therapy (OR, 2.68; 95% CI, 1.68–4.29). Conclusion: Cancer patients showed heterogeneity among their reasons for ED attendance and a high need for hospitalization and case fatality. Malignancy and general health status played a major role in the patient outcomes. This study suggests that the emergency care of cancer patients may be complex. Thus, studies to assess the impact of a dedicated oncology curriculum for ED physicians are warranted.
Collapse
Affiliation(s)
- Olivier Peyrony
- Department of Emergency Medicine, Saint-Louis University Hospital, Assistance Publique-Hôpitaux de Paris, 1 avenue Claude Vellefaux, 75010 Paris, France;
- Correspondence: ; Tel.: +33-1-42-49-84-04
| | - Jean-Paul Fontaine
- Department of Emergency Medicine, Saint-Louis University Hospital, Assistance Publique-Hôpitaux de Paris, 1 avenue Claude Vellefaux, 75010 Paris, France;
| | - Sébastien Beaune
- Department of Emergency Medicine, Ambroise Paré University Hospital, Assistance Publique-Hôpitaux de Paris, 92100 Boulogne-Billancourt, France;
- INSERM UMRS 1144, Paris-Descartes University, 75006 Paris, France
- Initiatives de Recherche aux Urgences (IRU) Research Network, Société Française de Médecine d’Urgence (SFMU), 75010 Paris, France; (A.K.); (J.T.)
| | - Abdo Khoury
- Initiatives de Recherche aux Urgences (IRU) Research Network, Société Française de Médecine d’Urgence (SFMU), 75010 Paris, France; (A.K.); (J.T.)
- Department of Emergency Medicine & Critical Care, Besançon University Hospital, 25000 Besançon, France
| | - Jennifer Truchot
- Initiatives de Recherche aux Urgences (IRU) Research Network, Société Française de Médecine d’Urgence (SFMU), 75010 Paris, France; (A.K.); (J.T.)
- Department of Emergency Medicine, SMUR, Lariboisière University Hospital, Assistance Publique-Hôpitaux de Paris, 75010 Paris, France
- Faculty of Medicine, Paris Diderot University, 75010 Paris, France
| | - Frédéric Balen
- Department of Emergency Medicine, Toulouse University Hospital, 31059 Toulouse, France;
- Faculty of Medicine, Toulouse III—Paul Sabatier University, 31330 Toulouse, France
| | - Rishad Vally
- Department of Emergency Medicine, SAMU 33, Pellegrin University Hospital, 33000 Bordeaux, France;
| | - Jacques Schmitt
- Department of Emergency Medicine, SAMU 68, Mulhouse Hospital, 68100 Mulhouse, France;
| | | | - Mélanie Roussel
- Department of Emergency Medicine, Rouen University Hospital, F-76031 Rouen, France;
| | - Céline Borzymowski
- Department of Emergency Médicine, Jean Bernard Hospital, 59322 Valenciennes, France;
| | - Cécile Vallot
- Department of Emergency Medicine, Annecy Genevois Hospital, 74370 Annecy, France;
| | - Veronique Sanh
- Department of Emergency Medicine, SAMU 95, René Dubos Hospital, 95300 Pontoise, France;
| | - Elie Azoulay
- Intensive Care Unit, Saint-Louis University Hospital, Assistance Publique-Hôpitaux de Paris, 75010 Paris, France;
- Centre of Research in Epidemiology and StatisticS (CRESS), INSERM, UMR 1153, Epidemiology and Clinical Statistics for Tumor, Respiratory, and Resuscitation Assessments (ECSTRRA) Team. University of Paris, 75010 Paris, France;
| | - Sylvie Chevret
- Centre of Research in Epidemiology and StatisticS (CRESS), INSERM, UMR 1153, Epidemiology and Clinical Statistics for Tumor, Respiratory, and Resuscitation Assessments (ECSTRRA) Team. University of Paris, 75010 Paris, France;
- Department of Biostatistics and Medical Information, Saint-Louis University Hospital, Assistance Publique-Hôpitaux de Paris, 75004 Paris, France
| |
Collapse
|
4
|
Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department. PLoS One 2020; 15:e0229828. [PMID: 32109264 PMCID: PMC7048306 DOI: 10.1371/journal.pone.0229828] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2019] [Accepted: 02/16/2020] [Indexed: 01/26/2023] Open
Abstract
Introduction The benefit of reducing the time of antibiotic initiation in the emergency department (ED) for neutropenic patients is controversial and the research on the impact of antibiotic adherence to international guidelines in the ED is scarce. We aimed to investigate the effect of antibiotic timing and appropriateness on outcomes in patients with febrile neutropenia (FN) and to assess the performance of the MASCC risk-index to risk-stratify such patients in the ED. Methods We prospectively identified patients with FN who presented to our ED and assessed their Multinational Association of Supportive Care in Cancer (MASCC) risk-index. The time to parenteral antibiotic initiation and the appropriateness of the antibiotic regimen according to international guidelines were retrospectively abstracted. The performance of the MASCC risk-index in predicting the absence of complication was assessed with sensitivity, specificity and the area under the receiver operating characteristics curve (AUC). We investigated the effect of the time to antibiotic initiation and the appropriateness of the antibiotic regimen on the outcome (ICU admission or death) by logistic regression analyses. Results We included 249 patients. Median age was 60 years and 67.9% had hematological malignancies, 26 (10.4%) were admitted to the ICU and 23 (9.8%) died during hospital stay. Among the 173 patients at low risk according to the MASCC risk-index, 56 (32.4%) presented at least one complication including 11 deaths. The MASCC risk-index had a sensitivity and a specificity of 0.78% and 0.43%, respectively, in predicting the absence of complication and the AUC was 0.67. The time to antibiotic initiation in the ED was not associated with the outcome after adjusting for performance status and shock-index. Conversely, an inadequate ED antibiotic regimen was associated with higher ICU admission or death during hospital stay (OR = 3.50; 95% CI = 1.49 to 8.28). Conclusion An inadequate ED antibiotic regimen in patients with FN was significantly associated with higher ICU admission or death during hospital stay.
Collapse
|